US 10889625
Peptide-based methods for treating neurological injury
granted A61KA61K31/37A61K31/40
Quick answer
US patent 10889625 (Peptide-based methods for treating neurological injury) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/37, A61K31/40, A61K31/401, A61K31/4184